National and Kapodistrian University of Athens
Μελέτη έκφρασης πρωτεϊνικών προϊόντων σε επίμυες των γονιδίων EGFR & ERBB3 που σχετίζονται με καρκινογένεση στη στοματική κοιλότητα
Abstract
dc:descriptionIntroduction: Oral squamous cell carcinoma (OSCC) is a malignancy that causes significant morbidity and mortality. Cancers that develop in the oral cavity are often not detected until the later stages of the disease when treatment options are limited. The major causative factors causing OSCC is tobacco and alcohol consumption. Oral carcinogenesis is a multistep process in which genetic events lead to disruption of the normal regulatory pathways that control basic cellular functions. These genetic events include chromosomal disorders, activation of oncogenes and inactivation of tumor suppressor genes. Therefore, understanding of the molecular mechanisms involved in the onset and progression of oral cancer will help to improve the prognosis and the development of new therapies. The epidermal growth factor receptor (EGFR) belongs to the family of transmembrane receptor tyrosine kinases type I and has the ability to stimulate the protein kinase pathways Ras- Raf-MEK-ERK or PLCg-Raf-MEK-ERK after its homodimerization. EGFR can also interact with other members of the family through the formation of heterodimers. ErbB3 is a receptor for heregulin belonging to the same family of tyrosine kinases with EGFR, but lacks intrinsic tyrosine kinase activity, therefore, in order to be activated, EGFR must be associated with other ErbBs.Purpose: The purpose of the present thesis is to investigate the possible association of EGFR and ErbB3 proteins with successive histological stages of OSCC formation. The selection of these genes was based on the important role they play in cellular processes such as embryogenesis, cell proliferation, differentiation and involvement in human oncogenesis in humans generally.Materials and methods: Thirty-seven male Syrian golden hamsters were used in the present study. The animals were randomly divided into four groups: one Control group (n=7) and three experimental groups for carcinogen treatment (A, B and C; n=10 animals each). The left buccal pouches of animals were treated with 0.5% 9,10-dimethyl-1,2-benzanthracene (DMBA), for 10 weeks (group A) and for 14 weeks (groups B and C). The histological status of the observed lesions in the three experimental groups correlated with tumor progression (from oral mucosal dysplasia to moderately differentiated squamous cell carcinoma). Tissue sections from normal mucosa to squamous cell carcinoma were studied, using monoclonal antibodies against the proteins. A statistical analysis was performed in each group and in each histological category.Results: A gradual progression was found, from normal mucosa to OSCC formation, compared with the increased time of application of the carcinogen, both macroscopically and microscopically. In the precancerous conditions (hyperplasia, dysplasia), a statistically significant increase in the expression of EGFR was demonstrated in comparison to normal mucosa (p <0.001). Similarly, in the statistical analysis performed between the tumour categories, a statistically significant increase was revealed in the stages of early invasion, well differentiated carcinoma and moderatelydifferentiated carcinoma in comparison to premalignant lesions (p <0.001). In addition, a statistically significant increase in EGFR expression was found in group A compared with the control group (p <0.001 ), in group B compared to group A (p <0.05), and in group B compared to group C (p <0.001). On the contrary, erbB3 or not expressed in normal or in tumor tissue.Conclusions: The experimental model of oral carcinogenesis in the buccal pouch of the Syrian golden hamsters using DMBA responds well to the gradual formation of OSCC and it may contribute to a better understanding of the mechanisms involved in the different stages of oral oncogenesis. EGFR plays a central role in carcinogenesis by the fact that it was increased from the early stages to the final stages of oral squamous cell carcinoma. Overexpression of EGFR from the early stages of cancer could be a reliable prognostic factor or serve as a target for anticancer therapy. Due to the absence of immunoreactivity of erbB3, it seems that erbB3 does not participate in signal transduction in normal or cancerous oral tissue. Possibly, another erbB factor, such as EGFR, plays a part in signal transduction.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Loukeri, Irini-Sofia
- Λουκέρη, Ειρήνη-Σοφία
Subjects
dc:subject × 14Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38476